Fulcrum Therapeutics, Inc. (FULC) — DEFA14A Filings
All DEFA14A filings from Fulcrum Therapeutics, Inc.. Browse 1 DEFA14A reports with AI-powered summaries and risk analysis.
DEFA14A Filings (1)
-
Fulcrum Therapeutics Files Proxy Materials
— Apr 30, 2026 Risk: low
Fulcrum Therapeutics, Inc. filed a Definitive Additional Materials (DEFA14A) on April 30, 2026. This filing is related to the solicitation of proxies. The compa
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX